Age-dependent influences on the origins of autoimmune diabetes: evidence and implications

RDG Leslie, MD Castelli - Diabetes, 2004 - Am Diabetes Assoc
RDG Leslie, MD Castelli
Diabetes, 2004Am Diabetes Assoc
Adecade ago we proposed that environmental factors operating in early life lead to type 1
diabetes, outlining the evidence and the implications if the hypothesis was true (1). Today
we can be confident that environmental factors can indeed operate in childhood to cause
type 1 diabetes, but we now review evidence that this is unlikely to be true in the generality
of cases of type 1 diabetes. Indeed, type 1 diabetes presenting in adult life is remarkably
distinct from diabetes presenting in children in terms of its genetic, immune, metabolic, and …
Adecade ago we proposed that environmental factors operating in early life lead to type 1 diabetes, outlining the evidence and the implications if the hypothesis was true (1). Today we can be confident that environmental factors can indeed operate in childhood to cause type 1 diabetes, but we now review evidence that this is unlikely to be true in the generality of cases of type 1 diabetes. Indeed, type 1 diabetes presenting in adult life is remarkably distinct from diabetes presenting in children in terms of its genetic, immune, metabolic, and clinical features. If the mechanism and timing of disease induction is also distinct in adult-onset, compared with childhood-onset, type 1 diabetes, then these differences would have implications for our understanding of the disease pathogenesis, prediction, and prevention. The aim of this article is to explore the different influences of genetic and nongenetic factors on type 1 diabetes according to the age of clinical disease onset and the potential consequences of such differences. Type 1 diabetes is caused by the destruction of insulinsecreting islet cells by an immune-mediated process. This adverse immune response is induced and promoted by the interaction of genetic and environmental factors and is one of a group of autoimmune diseases that affect 10% of the population in the developed world (2–5).
Am Diabetes Assoc